State privacy enforcement is entering a new phase, and Connecticut is quickly becoming a jurisdiction to watch. In its third annual Connecticut Data Privacy Act (CTDPA) enforcement report, the Office of Attorney General William Tong disclosed for the first time that it has opened multiple active investigations into how messaging platforms, gaming services, and AI
Latest from Ballard Spahr LLP - Page 2
What to Expect in AI Regulation in 2026
The past year set up a clear clash between federal deregulatory efforts and state-level AI rulemaking, and 2026 is poised to be the year that conflict materializes in earnest. The Trump Administration signaled a strong preference for scaling back AI-specific rules while exploring avenues to preempt state and local measures, even as a growing number
New York Governor Vetoes NY Health Privacy Act
On December 19, 2025, New York Governor Kathy Hochul vetoed the New York Health Information Privacy Act (NY HIPA), a health data privacy bill that would have afforded consumer protections to non-HIPAA health data.
Although NY HIPA resembled existing laws, like Washington’s My Health My Data Act, it had several important differences that would have
Progressive State Leaders Committee chooses Chopra to lead working group
The Progressive State Leaders Committee has tapped former CFPB Director Rohit Chopra to head a new Consumer Protection and Affordability Working Group. The Group is the 501(c) (4) affiliate of the Democratic Attorneys General Association.
“As part of its greater effort to tackle unfair and anticompetitive practices that drive up the cost of living and
Today’s podcast episode: AI in Financial Services: Understanding the White House Action Plan – and What It Leaves Out – Part 2
Today’s episode features Part 2 of our October 30, 2025 webinar, “AI in Financial Services: Understanding the White House Action Plan – and What It Leaves Out.” In this installment, our panel dives deeper into the evolving intersection of artificial intelligence, regulation, and innovation in financial services.
Moderated by Alan Kaplinsky, Senior Counsel, founder and
Today’s podcast episode: AI in Financial Services: Understanding the White House Action Plan – and What It Leaves Out – Part 1
Today’s episode features Part 1 of our October 30, 2025 webinar, “AI in Financial Services: Understanding the White House Action Plan – and What It Leaves Out.” In this installment, a panel of leading experts breaks down the rapidly evolving role of artificial intelligence in financial services—from foundational concepts to the latest regulatory developments.
Moderated
Today’s podcast episode: Fair Lending Developments Under Trump 2.0 – Part 2
Today’s episode marks the second of a two-part series, with Part One having been released on November 13th. In this installment, we continue our conversation on the many changes in fair lending policy and enforcement under the second Trump administration.
The discussion is moderated by Alan Kaplinsky, Senior Counsel, founder and former chair for 25
Today’s podcast episode: Fair Lending Developments Under Trump 2.0 – Part 1
Today’s episode marks the first of a two-part series, with Part Two scheduled for release on November 20th. In this installment, we examine the sweeping changes in fair lending policy and enforcement under the second Trump administration.
The discussion is moderated by Alan Kaplinsky, Senior Counsel, founder and former chair for 25 years of Ballard Spahr’s
Today’s podcast episode: Current State Statutes That Apply to AI in the Consumer Financial Services Industry
In this episode of the Consumer Finance Monitor podcast, host Alan Kaplinsky welcomes Pat Utz, CEO and co-founder of Abstract, a venture capital-backed AI company headquartered in New York. Pat brings extensive expertise on artificial intelligence. The podcast focuses on current developments in AI regulation and implementation, first covering President Trump’s recent “Winning the Race:
FDA Issues Guidance on AI for Medical Devices
The Food and Drug Administration (FDA) issued final guidance Monday that explains how medical device manufacturers can use a Predetermined Change Control Plan (PCCP) to update AI-enabled device software functions (AI-DSFs) after clearance or approval without submitting a new marketing application for each covered change.
The guidance is a practical how‑to for getting the FDA